Anucort-HC Suppository: Package Insert / Prescribing Information - Drugs.com

Skip to main content
Print
Save

# Anucort-HC Suppository

Package insert / prescribing information
Generic name: hydrocortisone acetate
Dosage form: rectal suppository
Drug class: Topical steroids

Medically reviewed by Drugs.com. Last updated on Jun 1, 2022.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. Read further information about unapproved drugs.

## Anucort-HC Suppository Description

Hydrocortisone Acetate is a corticosteroid designated chemically as pregn-4-ene 3, 20-dione,21-(acetyloxy)-11, 17-dihydroxy-(11ß) with the following structural formula:

Each rectal suppository contains hydrocortisone acetate, USP 25 mg in a specially blended hydrogenated vegetable oil base.

## Anucort-HC Suppository - Clinical Pharmacology

In normal subjects, about 26% of hydrocortisone acetate is absorbed when the suppository is applied to the rectum. Absorption of hydrocortisone acetate may vary across abraded or inflamed surfaces. Topical steroids are primarily effective because of their anti-inflammatory, anti-pruritic and vasoconstrictive action.

## INDICATIONS AND USAGE

Hydrocortisone acetate suppositories are indicated for use in inflamed hemorrhoids, post-irradiation (factitial) proctitis; as an adjunct in the treatment of chronic ulcerative colitis; cryptitis; and other inflammatory conditions of anorectum and pruritus ani.

## CONTRAINDICATIONS

Hydrocortisone acetate suppositories are contraindicated in those patients having a history of hypersensitivity to hydrocortisone acetate or any of the components.

## PRECAUTIONS

Do not use hydrocortisone acetate suppositories unless adequate proctologic examination is made.
If irritation develops, the product should be discontinued and appropriate therapy instituted.
In the presence of an infection, the use of an appropriate antifungal or antibacterial agent should be instituted. If a favorable response does not occur promptly, hydrocortisone acetate should be discontinued until the infection has been adequately controlled.
Carcinogenesis: No long term studies in animals have been performed to evaluate the carcinogenic potential of corticosteroid suppositories.

## INFORMATION FOR PATIENTS

Staining of fabric may occur with use of the suppository. Precautionary measures are recommended.

## PREGNANCY CATEGORY C

In laboratory animals, topical steroids have been associated with an increase in the incidence of fetal abnormalities when gestating females have been exposed to rather low dosage levels. There are no adequate and well controlled studies in pregnant women.
Hydrocortisone acetate suppositories should only be used during pregnancy if the potential benefit justifies the risk to the fetus. Drugs of this class should not be used extensively on pregnant patients, in large amounts, or for prolonged periods of time.
It is not known whether this drug is excreted in human milk and because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from hydrocortisone acetate suppositories, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

## Adverse Reactions

The following local adverse reactions have been reported with hydrocortisone acetate suppositories: burning, itching, irritation, dryness, folliculitis, hypopigmentation, allergic contact dermatitis, secondary infection.
To report SUSPECTED ADVERSE REACTIONS, contact Cosette Pharmaceuticals, Inc. at 1-800-922-1038 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

## DRUG ABUSE AND DEPENDENCE

Drug abuse and dependence have not been reported in patients treated with hydrocortisone acetate suppositories.

## Overdosage

If signs and symptoms of systemic overdosage occur, discontinue use.

## Anucort-HC Suppository Dosage and Administration

For rectal administration. Detach one suppository from strip of suppositories. Hold suppository upright. Separate tabs at top opening and pull downward from the pointed end. Continue pulling downward to almost the full length of the suppository. Carefully remove the suppository from the pocket. Avoid excessive handling of the suppository which is designed to melt at body temperature. Insert suppository into the rectum with gentle pressure, pointed end first. Insert one suppository in the rectum twice daily, morning and night for two weeks, in nonspecific proctitis. In more severe cases, one suppository three times a day or two suppositories twice daily. In factitial proctitis, the recommended duration of therapy is six to eight weeks or less, according to the response of the individual case.

## HOW SUPPLIED

Boxes of 12 suppositories NDC 0713-0503-12
Boxes of 24 suppositories NDC 0713-0503-24
Boxes of 100 suppositories NDC 0713-0503-01

## STORAGE AND HANDLING

Store at 20-25°C (68°-77°F) [See USP Controlled Room Temperature]. Store away from heat. Protect From Freezing.
Distributed by:

Cosette Pharmaceuticals, Inc.

South Plainfield, NJ 07080

8-0503CPLNC1

Iss. 12/2019 VC 7388

## PRINCIPAL DISPLAY PANEL

NDC 0713-0503-12

ANUCORT-HC TM

Hydrocortisone Acetate Suppositories

25 mg

Rx only

For Rectal Administration

12 Adult Suppositories

Cosette Pharmaceuticals, Inc.

NDC 0713-0503-24

ANUCORT-HC TM

Hydrocortisone Acetate Suppositories

25 mg

Rx only

For Rectal Administration

24 Adult Suppositories

Cosette Pharmaceuticals, Inc.

NDC 0713-0503-01

ANUCORT-HC TM

Hydrocortisone Acetate Suppositories

25 mg

Rx only

For Rectal Administration

100 Adult Suppositories

Cosette Pharmaceuticals, Inc.

HYDROCORTISONE ACETATE 25 mg

Distributed by:

Cosette Pharmaceuticals, Inc.

South Plainfield, NJ 07080

ANUCORT-HC hydrocortisone acetate suppository

Product Information
Product Type | HUMAN PRESCRIPTION DRUG LABEL | Item Code (Source) | NDC:0713-0503
Route of Administration | RECTAL | DEA Schedule |

Active Ingredient/Active Moiety
Ingredient Name | Basis of Strength | Strength
HYDROCORTISONE ACETATE (HYDROCORTISONE) | HYDROCORTISONE ACETATE | 25 mg

Inactive Ingredients
Ingredient Name | Strength
HYDROGENATED PALM KERNEL OIL |

Packaging
# | Item Code | Package Description
1 | NDC:0713-0503-12 | 12 SUPPOSITORY in 1 CARTON
2 | NDC:0713-0503-24 | 24 SUPPOSITORY in 1 CARTON
3 | NDC:0713-0503-01 | 100 SUPPOSITORY in 1 CARTON

Marketing Information
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date
unapproved drug other |  | 01/15/1990 |

Labeler - Cosette Pharmaceuticals, Inc. (116918230)

Registrant - Cosette Pharmaceuticals, Inc. (116918230)

Establishment
Name | Address | ID/FEI | Operations
Cosette Pharmaceuticals NC Laboratories, LLC |  | 079419931 | analysis(0713-0503), label(0713-0503), manufacture(0713-0503), pack(0713-0503)

Cosette Pharmaceuticals, Inc.

## More about Anucort-HC (hydrocortisone topical)

- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (3)
- Side effects
- Dosage information
- During pregnancy
- Drug class: topical steroids
- Breastfeeding
- En español

### Patient resources

- Drug Information

### Professional resources

- Prescribing Information
- Hydrocortisone in Absorbase (FDA)

#### Other brands

Westcort, Anusol-HC Suppositories, Proctozone HC, Procto-Med HC, ... +11 more

### Related treatment guides

- Hemorrhoids
- Pruritus
- Anal Itching

Medical Disclaimer